Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

A new paradigm of genetic testing for hereditary breast/ovarian cancers.

Kwong A, Chen JW, Shin VY.

Hong Kong Med J. 2016 Apr;22(2):171-7. doi: 10.12809/hkmj154634. Epub 2016 Mar 14. Review.

2.

Familial gastric cancer: genetic susceptibility, pathology, and implications for management.

Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F.

Lancet Oncol. 2015 Feb;16(2):e60-70. doi: 10.1016/S1470-2045(14)71016-2. Review.

PMID:
25638682
3.

Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.

Meaney-Delman D, Bellcross CA.

Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30. Review.

PMID:
24021253
4.

Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, Godwin AK.

Mol Oncol. 2009 Apr;3(2):97-137. doi: 10.1016/j.molonc.2009.02.004. Epub 2009 Feb 21. Review.

5.

Hereditary cancer syndromes.

Fostira F, Thodi G, Konstantopoulou I, Sandaltzopoulos R, Yannoukakos D.

J BUON. 2007 Sep;12 Suppl 1:S13-22. Review.

PMID:
17935271
6.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
7.

Clinical management of BRCA1 and BRCA2 mutation carriers.

Domchek SM, Weber BL.

Oncogene. 2006 Sep 25;25(43):5825-31. Review.

PMID:
16998496
8.

[Breast cancer screening different from that used for the general population: who is concerned and with which approach?].

Chappuis PO.

Rev Med Suisse. 2006 May 17;2(66):1296-8, 1301-2, 1304-5. Review. French.

PMID:
16775990
9.
10.
11.

Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.

Marchetti P, Di Rocco CZ, Ricevuto E, Bisegna R, Cianci G, Calista F, Sidoni T, Porzio G, Ficorella C.

Ann Oncol. 2004;15 Suppl 1:I27-I34. Review.

PMID:
15280184
12.

Recent developments in ovarian cancer genetics.

Barnett GL, Friedrich CA.

Curr Opin Obstet Gynecol. 2004 Feb;16(1):79-85. Review.

PMID:
15128012
13.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

14.

Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.

Lynch HT, Snyder CL, Lynch JF, Riley BD, Rubinstein WS.

J Clin Oncol. 2003 Feb 15;21(4):740-53. Review.

PMID:
12586815
15.

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

Hornreich G, Beller U, Lavie O, Renbaum P, Cohen Y, Levy-Lahad E.

Gynecol Oncol. 1999 Nov;75(2):300-4. Review.

PMID:
10525392
16.

[Tumor risk consultation for predisposed women from high risk cancer families].

Beckmann MW, Niederacher D, Bodden-Heidrich R, Goecke TO, Kuschel B, Achnoula M, Aba F, Schnürch HG, Bender HG.

Praxis (Bern 1994). 1998 Apr 8;87(15):511-5. Review. German.

PMID:
9608246
17.

Cancer in the family. Part 2.

Kefford R, Tucker K, Friedlander M, Kirk J.

Aust Fam Physician. 1998 Jan-Feb;27(1-2):40-4. Review.

PMID:
9503704
18.

Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?

Cole DE, Gallinger S, McCready DR, Rosen B, Engel J, Malkin D.

CMAJ. 1996 Jan 15;154(2):149-55. Review.

19.

[Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors].

Müller H, Scott RJ.

Schweiz Med Wochenschr. 1995 Jul 29;125(30):1445-54. Review. German.

PMID:
7676234
20.

Hereditary ovarian carcinoma.

Gallion HH, Smith SA.

Semin Surg Oncol. 1994 Jul-Aug;10(4):249-54. Review.

PMID:
8091066

Supplemental Content

Loading ...
Support Center